ReviewInfection2018
Evaluation and management of Staphylococcus aureus bacteriuria: an updated review.
Review in Infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 34 citations in OpenAlex.
- Characteristics of children with first febrile urinary tract infection caused by Staphylococcus species.European journal of pediatrics · 2026Observational
- Asymptomatic bacteriuria as a warning sign of purulent pericardial effusion in a patient with systemic lupus erythematosus: a case report.Journal of medical case reports · 2026Article
- The impact of an intervention to increase follow-up blood cultures for patients withAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025Article
- Risk of infective endocarditis and complicated infection in Staphylococcus aureus bacteremia - a retrospective cohort study on the role of bacteriuria.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024Article
- Purulent pericarditis caused by methicillin-sensitive Staphylococcus aureus bacteriuria.BMC cardiovascular disorders · 2024Article
- Article
- Livestock, pets and humans as carriers of methicillin-resistantVeterinary research forum : an international quarterly journal · 2023Article
- Article
- Article
- Presumed Urinary Tract Infection in Patients Admitted with COVID-19: Are We Treating Too Much?Antibiotics (Basel, Switzerland) · 2021Article
- Human Urine Alters Methicillin-Resistant Staphylococcus aureus Virulence and Transcriptome.Applied and environmental microbiology · 2021Article
- A Narrative Review on the Role ofOpen forum infectious diseases · 2021Review
- Purposeful microbiology comment added to urine cultures withAccess microbiology · 2021Article
- Erythropoietin Promotes Infection Resolution and Lowers Antibiotic Requirements inFrontiers in immunology · 2021Article
- Cuminaldehyde potentiates the antimicrobial actions of ciprofloxacin against Staphylococcus aureus and Escherichia coli.PloS one · 2020Article
- Article
- On the Etiological Relevance ofEuropean journal of microbiology & immunology · 2019Article
- Bioguided Purification of Active Compounds from Leaves ofBiomolecules · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsThere is little guidance regarding the evaluation and management of patients with Staphylococcus aureus bacteriuria (SABU). Here, we aimed to provide an up-to-date review of the literature.
methodsWe searched PubMed, Scopus, and clinical trial registries for articles evaluating the epidemiology of SABU, risk factors of SABU, the association of SABU with urinary tract infection, bacteremia and invasive S. aureus infections, and the management of patients with SABU.
resultsS. aureus is an uncommon isolate in urine cultures. It is more common among certain patients, e.g., patients with indwelling urinary tract devices or prior urinary tract instrumentation. SABU may represent asymptomatic bacteriuria, primary urinary tract infection, or hematogenous seeding of the urinary tract associated with other foci of infection. SABU may also serve as the focus for subsequent bacteremia and invasive infections. We did not find any clinical trials regarding the management of patients with SABU.
conclusionsBased on our review, we suggest an algorithmic approach for the evaluation and management of patients with SABU. However, evidence from clinical trials is lacking and there are several gaps in the current literature. These are discussed in this review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.